Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alok Kripal Tewari, M.D., Ph.D.

Concepts (211)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Alok Tewari's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Alok Tewari has written about over time.
Neoplasms, Hormone-Dependent, 2 publications between 2009 and 2013, average publication date April 2011. Metribolone, 1 publications between 2012 and 2012, average publication date October 2012. Sp1 Transcription Factor, 1 publications between 2012 and 2012, average publication date October 2012. Receptors, Androgen, 4 publications between 2009 and 2021, average publication date February 2014. Androgen Antagonists, 3 publications between 2009 and 2021, average publication date September 2014. Genomics, 2 publications between 2009 and 2021, average publication date February 2015. Orchiectomy, 3 publications between 2009 and 2023, average publication date May 2015. Transcription, Genetic, 3 publications between 2012 and 2021, average publication date June 2015. Chromatin, 4 publications between 2012 and 2022, average publication date May 2017. Prostatic Neoplasms, 9 publications between 2009 and 2024, average publication date June 2017. Antineoplastic Agents, Hormonal, 2 publications between 2013 and 2021, average publication date July 2017. Drug Resistance, Neoplasm, 3 publications between 2013 and 2021, average publication date October 2018. Nuclear Proteins, 4 publications between 2013 and 2023, average publication date April 2020. Disease Susceptibility, 1 publications between 2021 and 2021, average publication date January 2021. Prostate-Specific Antigen, 1 publications between 2021 and 2021, average publication date September 2021. Repressor Proteins, 2 publications between 2021 and 2023, average publication date October 2022. Neoplasms, Germ Cell and Embryonal, 3 publications between 2021 and 2023, average publication date November 2022. Testicular Neoplasms, 2 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Tewari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (211)
Explore
_
Co-Authors (65)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.